FSD Pharma Inc. Announces Termination of Chief Executive Officer Dr. Raza Bokhari for Cause
FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the Company or FSD) announced today that the board of directors had terminated the employment of the Companys Chief Executive Officer, Dr. Raza Bokhari for cause.
- FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the Company or FSD) announced today that the board of directors had terminated the employment of the Companys Chief Executive Officer, Dr. Raza Bokhari for cause.
- Anthony Durkacz, Zeeshan Saeed and Donal Carroll, directors who have been named by Dr. Bokhari in litigation, abstained from voting on the matter.
- The Companys board of directors has appointed Anthony Durkacz as the Companys interim Chief Executive Officer and Zeeshan Saeed was reinstated as the Companys President.
- I look forward to continue working with them to restore FSD and realize its full potential.